Psychosis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032
Psychosis is a mental disorder
characterized by a disconnect from reality, evident through a decline in daily
functioning and a breakdown of personality manifested as disturbances in
emotions, thoughts (like delusions), perceptions (such as hallucinations), and
behavior. The primary symptoms of psychosis include:
1. Hallucinations:
These involve perceiving things that aren't present, such as hearing, seeing,
or even feeling, smelling, or tasting things that have no physical existence.
Hearing voices is a common form of hallucination.
2. Delusions:
These are false beliefs that, upon rational examination, are untrue. Sometimes,
the cause of psychosis can be linked to specific mental health disorders,
including:
3. Schizophrenia
leads to various psychological symptoms, including hallucinations and
delusions.
4. Bipolar
disorder: A condition affecting mood, characterized by alternating episodes of
depression (lows) and mania (highs).
5. Severe
depression: In some cases, severe depression can also trigger symptoms of
psychosis.
Additionally, trauma, stress, physical
ailments like Parkinson's disease or brain tumors, as well as substance abuse
(drugs or alcohol) can all act as triggers for psychosis. Nonetheless, a
combination of genetic, biological, environmental, and psychological elements
is believed to play a role. Managing psychosis involves a combination of
approaches, including:
1. Antipsychotic
medication: These drugs help alleviate the symptoms of psychosis.
2. Psychological
therapies: Cognitive Behavioral Therapy (CBT), a one-on-one talking therapy,
has shown effectiveness in assisting individuals with schizophrenia. Family
therapy, where applicable, has been found to reduce the necessity for
hospitalization in people with psychosis.
3. Social
support: Addressing social needs like education, employment, and housing.
Individuals with a history of
psychosis are more likely to struggle with substance abuse issues or alcohol
misuse.
·
Around 3% of the population in the United
States will experience at least one episode of psychosis during their lifetime.
Annually, around 100,000 teenagers and young adults in the United States will
encounter their inaugural episode of psychosis.
Thelansis’s “Psychosis Market Outlook,
Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To
2032" covers disease overview, epidemiology, drug utilization,
prescription share analysis, competitive landscape, clinical practice,
regulatory landscape, patient share, market uptake, market forecast, and key
market insights under the potential Psychosis treatment modalities options for
eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights
of Psychosis across 8 MM market from the centre of Excellence/ Public/ Private
hospitals participated in the study. Insights around current treatment
landscape, epidemiology, clinical characteristics, future treatment paradigm,
and Unmet needs.
Psychosis Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment